HIV prevention drug backed by RTI International research takes step toward federal regulation Date Published: July 27, 2020 A technology for HIV prevention that’s been studied for years by researchers in the Triangle has taken a big leap…
Trump visit to highlight Triangle firm’s role in producing possible COVID-19 vaccine Date Published: July 27, 2020 RESEARCH TRIANGLE PARK – North Carolina’s global leadership in biomanufacturing has drawn a major spotlight with a White House announcement…
UNC, Baylor researchers report first successful lymphoma treatment using a cell therapy Date Published: July 27, 2020 CHAPEL HILL – CAR-T cell therapy, which attacks cancer cells using a person’s reprogrammed immune cells, has been used to…
Study: Believe or not, Triangle has third best commute in top 50 US metros Date Published: July 27, 2020 RESEARCH TRIANGLE PARK – Private sector and government officials are in the process of designing a new “FAST” regional transit…
Trump to see the ‘magic’ behind Covid-19 vaccine effort during Morrisville visit Date Published: July 24, 2020 The purpose of President Donald Trump’s upcoming visit to a Triangle biotech is simple: To see where the ‘magic’ happens,…
Triangle firm lands deal worth up to $310M for breast cancer treatment Date Published: July 23, 2020 RESEARCH TRIANGLE PARK – G1 Therapeutics has landed a licensing del worth up to $310 million not counting royalties for…
Suburbs & Mid-Size Cities Are In, Big Cities Are Out; Site Consultant Survey Finds Shifting Corporate Location Preferences Date Published: July 23, 2020 July 16, 2020 – Suburban areas and mid-size cities, followed by rural areas, will be the biggest winners of new…
GSK invests hundreds of millions in vaccine firm backed by Bill, Melinda Gates Date Published: July 20, 2020 RESEARCH TRIANGLE PARK – Drug giant GlaxoSmithKline is making a big bet on vaccines created around messenger RNA (mRNA) by…
RTP gene editing startup Locus Biosciences lands $12.5M from 31 investors Date Published: July 15, 2020 RESEARCH TRIANGLE PARK — Locus Biosciences, which is developing advanced antibacterial products with gene editing technology, has raised roughly $12.5…